Full-Time

Nurse Practitioner / Physician Assistant Manager

Nuclear Cardiology-MGH

Posted on 5/12/2026

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$130.2k - $190.3k/yr

Boston, MA, USA

In Person

On-site role; work location is 55 Fruit Street, Boston, MA.

Category
Medical, Clinical & Veterinary (2)
,
Required Skills
Management
Requirements
  • Current licensure as a Nurse Practitioner or Physician Assistant.
  • 5-7 years of Nurse Practitioner or Physician Assistant experience, required.
  • Prior Advanced Practice Provider management experience, required.
  • Demonstrated leadership or supervisory experience.
  • Knowledge of quality, safety, and regulatory standards in procedural or imaging environments.
  • Master's Degree in Physician Assistant (Education) is required.
  • Physician Assistant State License is required.
Responsibilities
  • Provides direct management and accountability for a team of Advanced Practice Providers and/or allied health professionals.
  • Recruits, hires, onboards, orients, and mentors APP staff.
  • Conducts performance evaluations, coaching, and professional development planning.
  • Works closely with APP Lead to develop staffing schedules to support clinical volumes and operational needs.
  • Provides patient care oversight as a Nurse Practitioner in Nuclear Cardiology and Molecular Imaging.
  • Oversees pre-procedure evaluations, risk stratification, and patient education for nuclear stress testing, positron emission tomography/computed tomography, PET/Magnetic Resonance imaging, and single-photon emission computed tomography imaging.
  • Collaborates with attending physicians on clinical decision-making, documentation, and care coordination.
  • Gains clinical competency in radiopharmaceuticals, stress agents, and imaging-related protocols.
  • Supports quality assurance and continuous quality improvement initiatives.
  • Ensures adherence to institutional policies, regulatory standards, and patient safety practices.
  • Oversees compliance with documentation and Advanced Practice Provider billing requirements.
  • Participates in incident reviews, root-cause analyses, and corrective action planning.
  • Ensures ongoing education, competency validation, and clinical training for APP staff.
  • Supports teaching and mentorship of trainees and new hires.
  • Encourages continuing education and specialty certification.
  • Acts as a liaison between APPs, physicians, technologists, nursing, operations, and leadership.
  • Collaborates to optimize workflow efficiency, patient throughput, and care coordination.
  • Contributes to service line planning and operational initiatives.
  • Performs all essential functions of a Physician Assistant, providing direct patient care.
  • Directly oversees and is accountable for the performance of a team of APPs and/or other direct reports.
  • Hires, performs, manages, and completes performance appraisals for a team of APPs and/or other direct reports.
  • Orients, trains, and schedules staff.
  • Assists with quality assurance programs as needed to help implement quality improvement efforts.
  • Ensures continuing education and teaching for APPs.
  • Acts as liaison between the hospital, physician and nursing staffs, and other APPs.
  • Ensures APPs are following proper billing compliance rules and methodology.
Desired Qualifications
  • Experience with nuclear medicine or molecular imaging workflows.
  • Familiarity with Advanced Practice Provider billing and compliance requirements.

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.7B

Headquarters

Cambridge, Massachusetts

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • 20 exits since inception including eight IPOs and twelve acquisitions demonstrate proven value creation.
  • Strategic focus on digital health and AI positions firm for high-growth healthcare innovation trends.
  • Integrated academic-clinical ecosystem provides technical validation and talent pipeline advantages.

What critics are saying

  • Escalating nurse strikes at Mass General Brigham disrupt operations and damage institutional reputation.
  • Portfolio company failures like Instride erode LP confidence and future fundraising capacity.
  • Competing VCs from non-MGB institutions capture superior deal flow, limiting proprietary advantage.

What makes Mass General Brigham unique

  • Proprietary deal flow from Mass General Brigham's research community and Harvard Medical School faculty.
  • Dedicated AI and Digital Innovation Fund targeting venture-stage healthcare companies since 2020.
  • Active company building support through Amplify program beyond capital provision.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Mass General Brigham who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.

CityBiz
Oct 7th, 2025
Affinia Therapeutics Secures $40M Series C

Avidity Partners has participated in a $40 million Series C funding round for Affinia Therapeutics, a company specializing in adeno-associated virus (AAV) gene therapies.

Business Wire
Oct 4th, 2025
Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubs...

PR Newswire
May 7th, 2025
Carta Healthcare Secures $18.25M Series B1 Funding

Carta Healthcare has secured $18 million in Series B1 funding to enhance its AI-powered clinical data abstraction and analytics. The investment, led by UPMC Enterprises with participation from several health ventures, will support Carta's growth in the life sciences market. The funding follows Carta's acquisition of Realyze Intelligence and aims to expand its customer base and improve healthcare data management. CEO Brent Dover highlighted the investment's role in scaling operations and product deployment.

Fierce Biotech
Feb 12th, 2025
Sanofi-backed Abcuro raises $200M series C to fund pivotal trial of KLRG1 antibody

Sanofi-backed Abcuro has secured